H. Vall Hebrón (Vall Hebron Institut de Oncologia - VHIO)

Barcelona 08035

0 studies enrolling now · 1 studies all time

What they study most

Advanced or Metastatic NSCLC

Studies at this site

• Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02) — Running, not enrolling